Advertisement

Stress, Inflammation, and Coronary Heart Disease

  • Andrew SteptoeEmail author
Chapter
  • 1.9k Downloads

Abstract

This chapter focuses on the contribution of inflammatory and immune processes to the links between stress and coronary heart disease (CHD). The aim is to demonstrate that the impact of stress on CHD development and prognosis is likely to be mediated in part through activation of innate and adaptive immune pathways, with inflammatory responses playing a major role. Understanding of these pathways may have implications for prevention and for the management of patients with established CHD.

Keywords

Stress Inflammation Coronary heart disease Atherosclerosis Acute coronary disease Immune function Hypertension Acute inflammatory stress responses 

References

  1. 1.
    Steptoe A, Brydon L. Psychosocial factors and coronary heart disease: the contribution of ­psychoneuroimmunological processes. In: Ader R, ed. Psychoneuroimmunology. 4th ed. San Diego: Academic Press; 2007:945-974.CrossRefGoogle Scholar
  2. 2.
    Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115-126.PubMedCrossRefGoogle Scholar
  3. 3.
    Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.PubMedCrossRefGoogle Scholar
  4. 4.
    Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129-2138.PubMedCrossRefGoogle Scholar
  5. 5.
    Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med. 2004;14:18-22.PubMedCrossRefGoogle Scholar
  6. 6.
    Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation. 2003;108:1772-1778.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of ­coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132-140.PubMedCrossRefGoogle Scholar
  8. 8.
    Elliott P, Chambers JC, Zhang W, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA. 2009;302:37-48.PubMedCrossRefGoogle Scholar
  9. 9.
    Danesh J, Pepys MB. C-reactive protein and coronary disease: is there a causal link? Circulation. 2009;120:2036-2039.PubMedCrossRefGoogle Scholar
  10. 10.
    Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78.PubMedCrossRefGoogle Scholar
  11. 11.
    Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108:2317-2322.PubMedCrossRefGoogle Scholar
  12. 12.
    Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294:1799-1809.PubMedCrossRefGoogle Scholar
  13. 13.
    Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170:191-203.PubMedCrossRefGoogle Scholar
  14. 14.
    Merten M, Thiagarajan P. P-selectin in arterial thrombosis. Z Kardiol. 2004;93:855-863.PubMedCrossRefGoogle Scholar
  15. 15.
    Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117:1449-1459.PubMedCrossRefGoogle Scholar
  16. 16.
    Tousoulis D, Antoniades C, Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart. 2007;93:1001-1007.PubMedCrossRefGoogle Scholar
  17. 17.
    Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-2618.PubMedCrossRefGoogle Scholar
  18. 18.
    Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601-610.PubMedCrossRefGoogle Scholar
  19. 19.
    Tonetti MS, D’Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356:911-920.PubMedCrossRefGoogle Scholar
  20. 20.
    Kushner I, Broder ML, Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest. 1978;61:235-242.PubMedCrossRefGoogle Scholar
  21. 21.
    Biasucci LM, Liuzzo G, Fantuzzi G, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 1999;99:2079-2084.PubMedCrossRefGoogle Scholar
  22. 22.
    Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol. 1998;31:1460-1465.PubMedCrossRefGoogle Scholar
  23. 23.
    Kosuge M, Ebina T, Hibi K, et al. Value of serial C-reactive protein measurements in non ST-segment elevation acute coronary syndromes. Clin Cardiol. 2008;31:437-442.PubMedCrossRefGoogle Scholar
  24. 24.
    Suleiman M, Khatib R, Agmon Y, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47:962-968.PubMedCrossRefGoogle Scholar
  25. 25.
    He LP, Tang XY, Ling WH, Chen WQ, Chen YM. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart. 2010;96:339-346.PubMedCrossRefGoogle Scholar
  26. 26.
    Fichtlscherer S, Heeschen C, Zeiher AM. Inflammatory markers and coronary artery disease. Curr Opin Pharmacol. 2004;4:124-131.PubMedCrossRefGoogle Scholar
  27. 27.
    Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA study. Am J Hypertens. 2004;17:568-573.PubMedCrossRefGoogle Scholar
  28. 28.
    Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945-2951.PubMedCrossRefGoogle Scholar
  29. 29.
    Tsakos G, Sabbah W, Hingorani AD, et al. Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey. J Hypertens. 2010;28(12):2386-2393.PubMedGoogle Scholar
  30. 30.
    Harrison DG, Guzik TJ, Lob HE, et al. Inflammation, immunity, and hypertension. Hypertension. 2011;57:132-140.PubMedCrossRefGoogle Scholar
  31. 31.
    Marvar PJ, Lob H, Vinh A, Zarreen F, Harrison DG. The central nervous system and inflammation in hypertension. Curr Opin Pharmacol. 2011;11(2):156-161.PubMedCrossRefGoogle Scholar
  32. 32.
    Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21.PubMedCrossRefGoogle Scholar
  33. 33.
    Steptoe A. Tools of psychosocial biology in health care research. In: Bowling A, Ebrahim S, eds. Handbook of Health Research Methods. Maidenhead: Open University Press; 2005:471-493.Google Scholar
  34. 34.
    Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-­analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601-630.PubMedCrossRefGoogle Scholar
  35. 35.
    Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21:901-912.PubMedCrossRefGoogle Scholar
  36. 36.
    von Kanel R, Kudielka BM, Preckel D, Hanebuth D, Fischer JE. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav Immun. 2006;20:40-48.CrossRefGoogle Scholar
  37. 37.
    Brydon L, Edwards S, Jia H, et al. Psychological stress activates interleukin-1 beta gene expression in human mononuclear cells. Brain Behav Immun. 2005;19:540-546.PubMedCrossRefGoogle Scholar
  38. 38.
    Dhabhar FS, McEwen BS. Bi-directional effects of stress on immune function: possible explanations for salubrious as well as harmful effects. In: Ader R, ed. Psychoneuroimmunology. 4th ed. San Diego: Academic Press; 2007:723-760.CrossRefGoogle Scholar
  39. 39.
    von Kanel R, Kudielka BM, Metzenthin P, et al. Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: a randomized, double-blind, placebo-controlled study. Brain Behav Immun. 2008;22:150-157.CrossRefGoogle Scholar
  40. 40.
    Goebel MU, Mills PJ. Acute psychological stress and exercise and changes in peripheral ­leukocyte adhesion molecule expression and density. Psychosom Med. 2000;62:664-670.PubMedGoogle Scholar
  41. 41.
    Redwine L, Snow S, Mills P, Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom Med. 2003;65:598-603.PubMedCrossRefGoogle Scholar
  42. 42.
    Ghiadoni L, Donald A, Cropley M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation. 2000;102:2473-2478.PubMedCrossRefGoogle Scholar
  43. 43.
    Adler NE, Rehkopf DH. U.S. disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health. 2008;29:235-252.PubMedCrossRefGoogle Scholar
  44. 44.
    Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303:1159-1166.PubMedCrossRefGoogle Scholar
  45. 45.
    Steptoe A, Marmot M. The role of psychobiological pathways in socio-economic inequalities in cardiovascular disease risk. Eur Heart J. 2002;23:13-25.PubMedCrossRefGoogle Scholar
  46. 46.
    Brydon L, Edwards S, Mohamed-Ali V, Steptoe A. Socioeconomic status and stress-induced increases in interleukin-6. Brain Behav Immun. 2004;18:281-290.PubMedCrossRefGoogle Scholar
  47. 47.
    Hamer M, Williams E, Vuonovirta R, Giacobazzi P, Gibson EL, Steptoe A. The effects of effort-reward imbalance on inflammatory and cardiovascular responses to mental stress. Psychosom Med. 2006;68:408-413.PubMedCrossRefGoogle Scholar
  48. 48.
    Steptoe A, Kunz-Ebrecht S, Owen N, et al. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med. 2003;65:137-144.PubMedCrossRefGoogle Scholar
  49. 49.
    Redwine L, Mills PJ, Sada M, Dimsdale J, Patterson T, Grant I. Differential immune cell chemotaxis responses to acute psychological stress in Alzheimer caregivers compared to non-caregiver controls. Psychosom Med. 2004;66:770-775.PubMedCrossRefGoogle Scholar
  50. 50.
    Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol. 2009;53:936-946.PubMedCrossRefGoogle Scholar
  51. 51.
    Gottdiener JS, Kop WJ, Hausner E, McCeney MK, Herrington D, Krantz DS. Effects of mental stress on flow-mediated brachial arterial dilation and influence of behavioral factors and hypercholesterolemia in subjects without cardiovascular disease. Am J Cardiol. 2003;92:687-691.PubMedCrossRefGoogle Scholar
  52. 52.
    Broadley AJ, Korszun A, Abdelaal E, et al. Inhibition of cortisol production with metyrapone prevents mental stress-induced endothelial dysfunction and baroreflex impairment. J Am Coll Cardiol. 2005;46:344-350.PubMedCrossRefGoogle Scholar
  53. 53.
    Brydon L, Strike PC, Bhattacharyya MR, et al. Hostility and physiological responses to ­laboratory stress in acute coronary syndrome patients. J Psychosom Res. 2010;68:109-116.PubMedCrossRefGoogle Scholar
  54. 54.
    Brydon L, Steptoe A. Stress-induced increases in interleukin-6 and fibrinogen predict ­ambulatory blood pressure at 3-year follow-up. J Hypertens. 2005;23:1001-1007.PubMedCrossRefGoogle Scholar
  55. 55.
    Ellins E, Halcox J, Donald A, et al. Arterial stiffness and inflammatory response to ­psychophysiological stress. Brain Behav Immun. 2008;22:941-948.PubMedCrossRefGoogle Scholar
  56. 56.
    Ramsay S, Lowe GD, Whincup PH, Rumley A, Morris RW, Wannamethee SG. Relationships of inflammatory and haemostatic markers with social class: results from a population-based study of older men. Atherosclerosis. 2008;197:654-661.PubMedCrossRefGoogle Scholar
  57. 57.
    Brunner E, Davey Smith G, Marmot M, Canner R, Beksinska M, O’Brien J. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet. 1996;347:1008-1013.PubMedCrossRefGoogle Scholar
  58. 58.
    Wamala SP, Murray MA, Horsten M, et al. Socioeconomic status and determinants of ­hemostatic function in healthy women. Arterioscler Thromb Vasc Biol. 1999;19:485-492.PubMedCrossRefGoogle Scholar
  59. 59.
    Nazmi A, Victora CG. Socioeconomic and racial/ethnic differentials of C-reactive protein ­levels: a systematic review of population-based studies. BMC Public Health. 2007;7:212.PubMedCrossRefGoogle Scholar
  60. 60.
    Loucks EB, Sullivan LM, Hayes LJ, et al. Association of educational level with inflammatory markers in the Framingham Offspring study. Am J Epidemiol. 2006;163:622-628.PubMedCrossRefGoogle Scholar
  61. 61.
    Friedman EM, Herd P. Income, education, and inflammation: differential associations in a national probability sample (the MIDUS study). Psychosom Med. 2010;72:290-300.PubMedCrossRefGoogle Scholar
  62. 62.
    Tabassum F, Kumari M, Rumley A, Lowe G, Power C, Strachan DP. Effects of socioeconomic position on inflammatory and hemostatic markers: a life-course analysis in the 1958 British birth cohort. Am J Epidemiol. 2008;167:1332-1341.PubMedCrossRefGoogle Scholar
  63. 63.
    Taylor SE, Lehman BJ, Kiefe CI, Seeman TE. Relationship of early life stress and psychological functioning to adult C-reactive protein in the coronary artery risk development in young adults study. Biol Psychiatry. 2006;60:819-824.PubMedCrossRefGoogle Scholar
  64. 64.
    Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA. 2007;104:1319-1324.PubMedCrossRefGoogle Scholar
  65. 65.
    Dong M, Giles WH, Felitti VJ, et al. Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation. 2004;110:1761-1766.PubMedCrossRefGoogle Scholar
  66. 66.
    Clays E, De Bacquer D, Delanghe J, Kittel F, Van Renterghem L, De Backer G. Associations between dimensions of job stress and biomarkers of inflammation and infection. J Occup Environ Med. 2005;47:878-883.PubMedCrossRefGoogle Scholar
  67. 67.
    Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA. 2003;100:9090-9095.PubMedCrossRefGoogle Scholar
  68. 68.
    Ranjit N, Diez-Roux AV, Shea S, et al. Psychosocial factors and inflammation in the ­multi-ethnic study of atherosclerosis. Arch Intern Med. 2007;167:174-181.PubMedCrossRefGoogle Scholar
  69. 69.
    Loucks EB, Berkman LF, Gruenewald TL, Seeman TE. Social integration is associated with fibrinogen concentration in elderly men. Psychosom Med. 2005;67:353-358.PubMedCrossRefGoogle Scholar
  70. 70.
    Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171-186.PubMedCrossRefGoogle Scholar
  71. 71.
    Goldman-Mellor S, Brydon L, Steptoe A. Psychological distress and circulating inflammatory markers in healthy young adults. Psychol Med. 2010;40:2079-2087.PubMedCrossRefGoogle Scholar
  72. 72.
    Poole L, Dickens C, Steptoe A. The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res. 2011;71:61-68.Google Scholar
  73. 73.
    Gimeno D, Kivimaki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39:413-423.PubMedCrossRefGoogle Scholar
  74. 74.
    Nabi H, Singh-Manoux A, Shipley M, Gimeno D, Marmot MG, Kivimaki M. Do psychological factors affect inflammation and incident coronary heart disease: the Whitehall II study. Arterioscler Thromb Vasc Biol. 2008;28:1398-1406.PubMedCrossRefGoogle Scholar
  75. 75.
    Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol. 2007;50:2044-2050.PubMedCrossRefGoogle Scholar
  76. 76.
    Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry. 2004;161:271-277.PubMedCrossRefGoogle Scholar
  77. 77.
    Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, Theroux P. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry. 2007;62:302-308.PubMedCrossRefGoogle Scholar
  78. 78.
    Schins A, Tulner D, Lousberg R, et al. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res. 2005;39:137-144.PubMedCrossRefGoogle Scholar
  79. 79.
    Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul study. Biol Psychiatry. 2007;62:314-320.PubMedCrossRefGoogle Scholar
  80. 80.
    Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J. 2005;150:132-136.PubMedCrossRefGoogle Scholar
  81. 81.
    Parissis JT, Adamopoulos S, Rigas A, et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol. 2004;94:1326-1328.PubMedCrossRefGoogle Scholar
  82. 82.
    Mommersteeg PM, Kupper N, Schoormans D, Emons W, Pedersen SS. Health-related quality of life is related to cytokine levels at 12 months in patients with chronic heart failure. Brain Behav Immun. 2010;24:615-622.PubMedCrossRefGoogle Scholar
  83. 83.
    Denollet J, Conraads VM, Brutsaert DL, De Clerck LS, Stevens WJ, Vrints CJ. Cytokines and immune activation in systolic heart failure: the role of type D personality. Brain Behav Immun. 2003;17:304-309.PubMedCrossRefGoogle Scholar
  84. 84.
    Denollet J, Schiffer AA, Kwaijtaal M, et al. Usefulness of type D personality and kidney ­dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure. Am J Cardiol. 2009;103:399-404.PubMedCrossRefGoogle Scholar
  85. 85.
    Wirtz PH, Redwine LS, Linke S, et al. Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients. Brain Behav Immun. 2010;24:366-369.PubMedCrossRefGoogle Scholar
  86. 86.
    Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24-31.PubMedCrossRefGoogle Scholar
  87. 87.
    Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to ­sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46-56.PubMedCrossRefGoogle Scholar
  88. 88.
    Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21:153-160.PubMedCrossRefGoogle Scholar
  89. 89.
    Hingorani AD, Cross J, Kharbanda RK, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994-999.PubMedCrossRefGoogle Scholar
  90. 90.
    Strike PC, Wardle J, Steptoe A. Mild acute inflammatory stimulation induces transient negative mood. J Psychosom Res. 2004;57:189-194.PubMedCrossRefGoogle Scholar
  91. 91.
    Wright CE, Strike PC, Brydon L, Steptoe A. Acute inflammation and negative mood: ­mediation by cytokine activation. Brain Behav Immun. 2005;19:345-350.PubMedCrossRefGoogle Scholar
  92. 92.
    Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009;66:407-414.PubMedCrossRefGoogle Scholar
  93. 93.
    Harrison NA, Brydon L, Walker C, et al. Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry. 2009;66:415-422.PubMedCrossRefGoogle Scholar
  94. 94.
    Crossman DC, Morton AC, Gunn JP, et al. Investigation of the effect of interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (the MRC-ILA-HEART study). Trials. 2008;9:8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Department of Epidemiology and Public HealthUniversity College LondonLondonUK

Personalised recommendations